Deltex Medical Regulatory News (DEMG)

23 Nov 2006 15:05

Deltex Medical Group PLC23 November 2006 Deltex Medical Group plc Directors' Shareholdings Deltex Medical Group plc ("Deltex Medical" or the "Company"), the UK's leadinghaemodynamic monitoring company, announces that it has today issued a total of369,812 new ordinary shares in the Company to certain non-executive directorsand certain advisors to the Company at a price of 18.50 pence per share. The five non-executive directors named below have elected to take shares in lieuof a cash payment as remuneration for their services to the Company. Inaddition certain of the Company's advisors have elected to take shares in lieuof cash payment for their services to the Company. Accordingly, application has been made for these shares to be admitted totrading on AIM. The shares rank pari passu with the existing issued shares ofthe Company and dealings are expected to commence on () December 2006.Following the issue of these new shares the Company has a total of 80,057,125ordinary shares in issue. Following this issue, the directors' beneficial interests are as follows: Name of Director Number of new Holding of shares following % of enlarged issued ordinary shares issue of new ordinary shares share capital issued in lieu of fees Nigel Keen (1) 67,568 4,255,114 5.31%Dr Edwin Snape (2) 48,649 3,256,399 4.06%Peter Smedvig (3) 48,649 1,190,764 1.49%Andy Hill - 172,486 0.22%Ewan Phillips - 767,156 0.96%George Flouty 48,649 343,984 0.43%Sir Duncan Nichol 37,946 108,961 0.14% Total 251,461 10,094,864 12.61% (1) Includes 589,700 shares held as trustee and executor of Pauline ThomasCharity Will Trust. (2) Includes shares held as a director of New England Partners andassociated companies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837Nigel Keen, ChairmanAndy Hill, Chief ExecutiveEwan Phillips, Finance Director Charles Stanley 0207 953 2000Philip Davies Gavin AndersonDeborah Walter/Marie Cairney/Jodie Reilly 0207 554 1400 This information is provided by RNS The company news service from the London Stock Exchange